FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096632 [Registered on: 30/10/2025] Trial Registered Prospectively
Last Modified On: 29/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of magnetic stimulation by accelerated iTBS in negative symptoms of schizophrenia  
Scientific Title of Study   Efficacy of accelerated intermittent theta burst stimulation (iTBS) on negative symptoms among individuals with Schizophrenia: A randomised sham controlled study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vaishnavi Raj 
Designation  Junior Resident, Psychiatry 
Affiliation  Institute of medical sciences, BHU 
Address  Plot no 105, Ramjaipal Nagar, Gola Road, Danapur Cantt, Patna
Department of Psychiatry, Institute of medical sciences, BHU
Patna
BIHAR
801503
India 
Phone  07518816580  
Fax    
Email  rajv1919@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Pankaj Gupta 
Designation  Assistant Professor, Psychiatry 
Affiliation  Institute of medical sciences, BHU 
Address  Sir Sunderlal Hospital, Trauma Center Complex, Department of Psychiatry, BHU, Varanasi, Uttar Pradesh, 221005

Varanasi
UTTAR PRADESH
221005
India 
Phone  9990556662  
Fax    
Email  pankajg0891@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vaishnavi Raj 
Designation  Junior Resident, Psychiatry 
Affiliation  Institute of medical sciences, BHU 
Address  Plot no 105, Ramjaipal Nagar, Gola Road, Danapur Cantt, Patna
Department of Psychiatry, Institute of medical sciences, BHU

BIHAR
801503
India 
Phone  07518816580  
Fax    
Email  rajv1919@gmail.com  
 
Source of Monetary or Material Support  
Sir Sunderlal Hospital, Trauma Center Complex, Department of Psychiatry, BHU, Varanasi, Uttar Pradesh, 221005 
 
Primary Sponsor  
Name  Sir Sunderlal Hospital 
Address  Trauma center Complex, Department of psychiatry, BHU, Varanasi, Uttar Pradesh, 221005 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vaishnavi Raj  Sir Sunderlal Hospital  Trauma center complex, Department of Psychiatry, 4th floor, rTMS room
Varanasi
UTTAR PRADESH 
7518816580

rajv1919@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F20||Schizophrenia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Accelerated iTBS   Accelerated iTBS will be performed using NEURO-MS.NET - magnetic stimulator software (version 3.2.10.1). The left DLPFC region of the brain will be targeted using neural navigation by software- neural navigator. The coil will produce 3 pulses of 50 Hz burst, given for 1.8 seconds with 8 seconds of inter-train interval. Therefore, a total of 5 Hz train frequency will be given for treatment. A 3 minutes protocol which will deliver 600 pulses in one session will be delivered. Similar session will be provided thrice a day for 5 days/week for 2 weeks, thus delivering a total of 1800 pulses per day for 10 days. 
Comparator Agent  Sham iTBS  Sham iTBS using sham coil of rTMS of same duration as of active intervention in similar settings. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Diagnosis of schizophrenia using diagnostic criteria of international classification of disease- 11th edition (ICD-11)
2.Male or female of age between 18 years to 60 years
3.Schizophrenia patients who haven’t received rTMS or ECT in the past 6 months
4.The Positive and negative syndrome scale for schizophrenia- negative symptoms score of more than 15
5.Scale for assessment of negative symptoms score more than 20
6.Willingness to give informed consent
 
 
ExclusionCriteria 
Details  1.Presence of comorbid neurological, medical or other psychiatric disorder that are interfering with the study or patient being unmanageable due to acute illness or severity of the existing disorder
2.Patients with comorbid substance dependence, except nicotine and caffeine
3.Having any metallic implants/parts in body
4.Patients having a history of head trauma with loss of consciousness
5.Patients with a history of seizure/convulsion or having epilepsy or family history of same.
6.Patients with raised intracranial tension
7.Patients with a history of neurosurgery of any type ( brain or spinal cord) 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1.To assess the efficacy of accelerated intermittent theta burst stimulation in negative symptoms of patients with schizophrenia
2.To compare the efficacy of accelerated intermittent theta burst stimulation in negative symptoms of schizophrenia patients with that of the control group 
Baseline and 2 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the efficacy of accelerated intermittent theta burst stimulation in positive symptoms of patients with schizophrenia
To compare the efficacy of accelerated intermittent theta burst stimulation in positive symptoms of schizophrenia patients with that of the control group 
Baseline and 2 weeks 
To assess the efficacy of accelerated intermittent theta burst stimulation in cognitive functions of patients with schizophrenia
To compare the efficacy of accelerated intermittent theta burst stimulation in cognitive functions of schizophrenia patients with that of the control group 
Baseline and 2 weeks 
To assess the safety and tolerance of accelerated iTBS in patients with schizophrenia  Baseline, 1 week and 2 weeks 
 
Target Sample Size   Total Sample Size="82"
Sample Size from India="82" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Study design - Randomized controlled trial, with study topic of EFFICACY OF ACCELERATED INTERMITTENT THETA BURST STIMULATION (iTBS) ON NEGATIVE SYMPTOMS AMONG INDIVIDUALS WITH SCHIZOPHRENIA: A RANDOMISED SHAM CONTROLLED STUDY,  being carried out in department of Psychiatry, IMS BHU Varanasi with sample size of 82 cases including accelerated iTBS protocol for 2 weeks with pre and post interventional assessments. 
Close